Company / Current Liabilities per Share
IGC Pharma, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.03
FY2025
5-year range
$0.03 / $0.06
FY2021-FY2025
Trend
-36.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.03 in FY2025 to $2.46 in FY2016.
Based on SEC 10-K filings.
0.03 in FY2025 with a 5-year CAGR of -10.7%.
Improved from $0.04 to $0.03 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -18.2%
- 5-Year CAGR
- -10.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 36.7% year-over-year.
- Peak current liabilities per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | -36.7% |
| FY2024 | $0.04 | +18.6% |
| FY2023 | $0.04 | -27.2% |
| FY2022 | $0.05 | -15.3% |
| FY2021 | $0.06 | +22.2% |
| FY2020 | $0.05 | +72.6% |
| FY2019 | $0.03 | -65.6% |
| FY2018 | $0.08 | +49.7% |
| FY2017 | $0.06 | -97.7% |
| FY2016 | $2.46 | +30.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026